Osaic Holdings’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
CP
BCM
VCM
BCM
ACM
PA
Osaic Holdings's IRD Position: Q1 2026 in Review
Osaic Holdings reduced its Opus Genetics (IRD) stake by 84% in Q1 2026, selling an estimated $40.5K and leaving 2,200 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #6292.
Osaic Holdings first reported a position in IRD in Q1 2020 and has held it in 25 quarters since. The position peaked at $142K in Q2 2023. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.
- Osaic Holdings held 2,200 shares of Opus Genetics worth $10K as of Q1 2026.
- Osaic Holdings sold 11,700 Opus Genetics shares in Q1 2026, an estimated $40.5K.
- Opus Genetics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6292 holding.
- Osaic Holdings first reported a position in Opus Genetics in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Opus Genetics position peaked at $142K in Q2 2023.
- 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.